BeOne Medicines Ltd. (BEIGF) › RevenueBeOne Medicines Ltd. (BEIGF) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $1.07M2017: $238.39M2018: $198.22M2019: $428.21M2020: $308.87M2021: $1.18B2022: $1.42B2023: $2.46B2024: $3.81B2025: $5.34B$5.34B2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$5.34B+40.2%2024$3.81B+55.0%2023$2.46B+73.7%2022$1.42B+20.4%2021$1.18B+280.8%2020$308.87M-27.9%2019$428.21M+116.0%2018$198.22M-16.8%2017$238.39M+22179.2%2016$1.07M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share